Medical societies, patient education initiatives, public debate and marketing of unproven stem cell interventions

Daniel J. Weiss, Leigh Turner, Aaron D. Levine, Laertis Ikonomou

Research output: Contribution to journalArticlepeer-review

12 Scopus citations

Abstract

Businesses marketing unproven stem cell interventions proliferate within the U.S. and in the larger global marketplace. There have been global efforts by scientists, patient advocacy groups, bioethicists, and public policy experts to counteract the uncontrolled and premature commercialization of stem cell interventions. In this commentary, we posit that medical societies and associations of health care professionals have a particular responsibility to be an active partner in such efforts. We review the role medical societies can and should play in this area through patient advocacy and awareness initiatives

Original languageEnglish (US)
Pages (from-to)165-168
Number of pages4
JournalCytotherapy
Volume20
Issue number2
DOIs
StatePublished - Feb 2018

Keywords

  • health care professionals
  • medical societies
  • patients
  • unproven stem cell interventions
  • “stem cell” clinics

Fingerprint Dive into the research topics of 'Medical societies, patient education initiatives, public debate and marketing of unproven stem cell interventions'. Together they form a unique fingerprint.

Cite this